Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about AdverumBiotechnologiesInc-2020-08-12
$216.8 Million
Image
Adverum Biotechnologies, Inc.
Follow-On Offering
Active Bookrunner
Read more
about CytokineticsIncorporated-2020-07-21
$201.0 Million
Image
Cytokinetics, Incorporated
Follow-On Offering
Active Bookrunner
Read more
about TCR2Therapeutics-2020-07-31
$142.6 Million
Image
TCR2 Therapeutics
Follow-On Offering
Active Bookrunner
Read more
about MiratiTherapeuticsInc-2020-10-27
$1.0 Billion
Image
Mirati Therapeutics, Inc.
Follow-On Offering
Passive Bookrunner
Read more
about AcceleronPharmaInc-2020-07-01
$517.5 Million
Image
Acceleron Pharma, Inc.
Follow-On Offering
Passive Bookrunner
Read more
about TELABioInc-2020-06-25
$48.0 Million
Image
TELA Bio, Inc.
Follow-On Offering
Active Bookrunner
Read more
about 1LifeHealthcareInc-2020-06-25
$257.3 Million
Image
1Life Healthcare, Inc.
Follow-On Offering
Passive Bookrunner
Read more
about AllogeneTherapeuticsInc-2020-06-02
$632.5 Million
Image
Allogene Therapeutics, Inc.
Follow-On Offering
Passive Bookrunner
Read more
about OysterPointPharmaInc-2020-05-14
$120.8 Million
Image
Oyster Point Pharma, Inc.
Follow-On Offering
Active Bookrunner
Read more
about ImmunomedicsInc-2020-04-28
$483.0 Million
Image
Immunomedics Inc.
Follow-On Offering
Co-Manager
Pagination
Previous page
‹‹
Page 50
Next page
››
Subscribe to Equity Capital Markets
